Alexander Piening
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alexander Piening has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Ryan M. Teague
Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri
21 shared publications - Maureen J. Donlin
Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, Missouri, USA
17 shared publications - Richard J. DiPaolo
Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, Saint Louis, Missouri, USA
17 shared publications - Elise Alspach
Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri
16 shared publications - Chinye Nwokolo
Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri. 2
15 shared publications - David DeBruin
Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, Missouri, USA
15 shared publications
Latest Publications
- 6 November 2026
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
Parental obesity is associated with altered hematopoiesis and impaired viral immunity in offspring
The prevalence of obesity among adults of childbearing age has tripled worldwide since 1975. Obesity during pregnancy has been linked to impaired neonatal immunity and a higher risk of infections in childhood but the causal mechanisms have not been defined. Using a mouse model of diet-induced obesity, we documented impaired antiviral immunity in the offspring of obese mice, corresponding with reduced cell-mediated immune responses. This included lower frequencies of Tbet+ CD4+ T helper 1 cells and a decrease in cytotoxic CD8+ T cells in the lungs of mice infected with respiratory Sendai virus, and confirmed in spleens from mice infected with LCMV. Consistent with impaired cellular immunity, single-cell transcriptomic analysis of bone marrow revealed altered hematopoiesis in these offspring, with evidence of interferon-induced skewing toward myelopoiesis at the expense of lymphocyte development. Our studies provide an in-depth transcriptomic profile of immune cell progenitors in the bone marrow paired with mature innate and adaptive immune cell populations in lymph nodes at single-cell resolution. Results suggest that compromised immune protection from viral infections in the offspring of obese mice stems from altered lymphocyte development that is influenced by inflammatory interferon signaling in bone marrow.
- 6 November 2026
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
Parental obesity is associated with altered hematopoiesis and impaired viral immunity in offspring
The prevalence of obesity among adults of childbearing age has tripled worldwide since 1975. Obesity during pregnancy has been linked to impaired neonatal immunity and a higher risk of infections in childhood but the causal mechanisms have not been defined. Using a mouse model of diet-induced obesity, we documented impaired antiviral immunity in the offspring of obese mice, corresponding with reduced cell-mediated immune responses. This included lower frequencies of Tbet+ CD4+ T helper 1 cells and a decrease in cytotoxic CD8+ T cells in the lungs of mice infected with respiratory Sendai virus, and confirmed in spleens from mice infected with LCMV. Consistent with impaired cellular immunity, single-cell transcriptomic analysis of bone marrow revealed altered hematopoiesis in these offspring, with evidence of interferon-induced skewing toward myelopoiesis at the expense of lymphocyte development. Our studies provide an in-depth transcriptomic profile of immune cell progenitors in the bone marrow paired with mature innate and adaptive immune cell populations in lymph nodes at single-cell resolution. Results suggest that compromised immune protection from viral infections in the offspring of obese mice stems from altered lymphocyte development that is influenced by inflammatory interferon signaling in bone marrow.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 3 from T-Cell Expression of CXCL13 is Associated with Immunotherapy Response in a Sex-Dependent Manner in Patients with Lung Cancer
Supplemental Figure 3: Characterization of CD4+ and CD8+ T cell populations infiltrating tumors from male and female patients with NSCLC from Liu et al.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 3 from T-Cell Expression of CXCL13 is Associated with Immunotherapy Response in a Sex-Dependent Manner in Patients with Lung Cancer
Supplemental Figure 3: Characterization of CD4+ and CD8+ T cell populations infiltrating tumors from male and female patients with NSCLC from Liu et al.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 4 from T-Cell Expression of CXCL13 is Associated with Immunotherapy Response in a Sex-Dependent Manner in Patients with Lung Cancer
Supplemental Figure 4: TCR repertoire analysis reveals sex-based differences in the association between T cell clonal expansion and expression of CXCL13.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 4 from T-Cell Expression of CXCL13 is Associated with Immunotherapy Response in a Sex-Dependent Manner in Patients with Lung Cancer
Supplemental Figure 4: TCR repertoire analysis reveals sex-based differences in the association between T cell clonal expansion and expression of CXCL13.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 2 from T-Cell Expression of CXCL13 is Associated with Immunotherapy Response in a Sex-Dependent Manner in Patients with Lung Cancer
Supplemental Figure 2: Sex-based differences in CXCL13 expression level and frequency of CXCL13+ T cells.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 2 from T-Cell Expression of CXCL13 is Associated with Immunotherapy Response in a Sex-Dependent Manner in Patients with Lung Cancer
Supplemental Figure 2: Sex-based differences in CXCL13 expression level and frequency of CXCL13+ T cells.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 1 from T-Cell Expression of CXCL13 is Associated with Immunotherapy Response in a Sex-Dependent Manner in Patients with Lung Cancer
Supplemental Figure 1: Characterization of CD4+ and CD8+ T cell populations infiltrating tumors from male and female patients with NSCLC.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 1 from T-Cell Expression of CXCL13 is Associated with Immunotherapy Response in a Sex-Dependent Manner in Patients with Lung Cancer
Supplemental Figure 1: Characterization of CD4+ and CD8+ T cell populations infiltrating tumors from male and female patients with NSCLC.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Data from T-Cell Expression of CXCL13 is Associated with Immunotherapy Response in a Sex-Dependent Manner in Patients with Lung Cancer
Emerging evidence in preclinical models demonstrates that antitumor immunity is not equivalent between males and females. However, more investigation in patients and across a wider range of cancer types is needed to fully understand sex as a variable in tumor immune responses. We investigated differences in T-cell responses between male and female patients with lung cancer by performing sex-based analysis of single cell transcriptomic datasets. We found that the transcript encoding CXC motif chemokine ligand 13 (CXCL13), which has recently been shown to correlate with T-cell tumor specificity, is expressed at greater levels in T cells isolated from female compared with male patients. Furthermore, increased CXCL13 expression was associated with response to PD1–targeting immunotherapy in female but not male patients. These findings suggest that there are sex-based differences in T-cell function required for response to anti–PD1 therapy in lung cancer that may need to be considered during patient treatment decisions.See related Spotlight by Cruz-Hinojoza and Stromnes, p. 952
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from T-Cell Expression of CXCL13 is Associated with Immunotherapy Response in a Sex-Dependent Manner in Patients with Lung Cancer
Emerging evidence in preclinical models demonstrates that antitumor immunity is not equivalent between males and females. However, more investigation in patients and across a wider range of cancer types is needed to fully understand sex as a variable in tumor immune responses. We investigated differences in T-cell responses between male and female patients with lung cancer by performing sex-based analysis of single cell transcriptomic datasets. We found that the transcript encoding CXC motif chemokine ligand 13 (CXCL13), which has recently been shown to correlate with T-cell tumor specificity, is expressed at greater levels in T cells isolated from female compared with male patients. Furthermore, increased CXCL13 expression was associated with response to PD1–targeting immunotherapy in female but not male patients. These findings suggest that there are sex-based differences in T-cell function required for response to anti–PD1 therapy in lung cancer that may need to be considered during patient treatment decisions.See related Spotlight by Cruz-Hinojoza and Stromnes, p. 952
- Open Access
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 1 from T-Cell Expression of CXCL13 is Associated with Immunotherapy Response in a Sex-Dependent Manner in Patients with Lung Cancer
Supplemental Figure 1: Characterization of CD4+ and CD8+ T cell populations infiltrating tumors from male and female patients with NSCLC.
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 1 from T-Cell Expression of CXCL13 is Associated with Immunotherapy Response in a Sex-Dependent Manner in Patients with Lung Cancer
Supplemental Figure 1: Characterization of CD4+ and CD8+ T cell populations infiltrating tumors from male and female patients with NSCLC.
- Open Access
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 2 from T-Cell Expression of CXCL13 is Associated with Immunotherapy Response in a Sex-Dependent Manner in Patients with Lung Cancer
Supplemental Figure 2: Sex-based differences in CXCL13 expression level and frequency of CXCL13+ T cells.
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 2 from T-Cell Expression of CXCL13 is Associated with Immunotherapy Response in a Sex-Dependent Manner in Patients with Lung Cancer
Supplemental Figure 2: Sex-based differences in CXCL13 expression level and frequency of CXCL13+ T cells.
- Open Access
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Data from T-Cell Expression of CXCL13 is Associated with Immunotherapy Response in a Sex-Dependent Manner in Patients with Lung Cancer
Emerging evidence in preclinical models demonstrates that antitumor immunity is not equivalent between males and females. However, more investigation in patients and across a wider range of cancer types is needed to fully understand sex as a variable in tumor immune responses. We investigated differences in T-cell responses between male and female patients with lung cancer by performing sex-based analysis of single cell transcriptomic datasets. We found that the transcript encoding CXC motif chemokine ligand 13 (CXCL13), which has recently been shown to correlate with T-cell tumor specificity, is expressed at greater levels in T cells isolated from female compared with male patients. Furthermore, increased CXCL13 expression was associated with response to PD1–targeting immunotherapy in female but not male patients. These findings suggest that there are sex-based differences in T-cell function required for response to anti–PD1 therapy in lung cancer that may need to be considered during patient treatment decisions.See related Spotlight by Cruz-Hinojoza and Stromnes, p. 952
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from T-Cell Expression of CXCL13 is Associated with Immunotherapy Response in a Sex-Dependent Manner in Patients with Lung Cancer
Emerging evidence in preclinical models demonstrates that antitumor immunity is not equivalent between males and females. However, more investigation in patients and across a wider range of cancer types is needed to fully understand sex as a variable in tumor immune responses. We investigated differences in T-cell responses between male and female patients with lung cancer by performing sex-based analysis of single cell transcriptomic datasets. We found that the transcript encoding CXC motif chemokine ligand 13 (CXCL13), which has recently been shown to correlate with T-cell tumor specificity, is expressed at greater levels in T cells isolated from female compared with male patients. Furthermore, increased CXCL13 expression was associated with response to PD1–targeting immunotherapy in female but not male patients. These findings suggest that there are sex-based differences in T-cell function required for response to anti–PD1 therapy in lung cancer that may need to be considered during patient treatment decisions.See related Spotlight by Cruz-Hinojoza and Stromnes, p. 952
- Open Access
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 4 from T-Cell Expression of CXCL13 is Associated with Immunotherapy Response in a Sex-Dependent Manner in Patients with Lung Cancer
Supplemental Figure 4: TCR repertoire analysis reveals sex-based differences in the association between T cell clonal expansion and expression of CXCL13.
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 4 from T-Cell Expression of CXCL13 is Associated with Immunotherapy Response in a Sex-Dependent Manner in Patients with Lung Cancer
Supplemental Figure 4: TCR repertoire analysis reveals sex-based differences in the association between T cell clonal expansion and expression of CXCL13.